Please login to the form below

Not currently logged in
Email:
Password:

Ozempic

This page shows the latest Ozempic news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk set to acquire Emisphere Technology for $1.8bn

Novo Nordisk set to acquire Emisphere Technology for $1.8bn

Rothwell, chairman of Emisphere. Novo’s GLP-1 agonist franchise also includes Ozempic (semglutide) and Victoza (liraglutide).

Latest news

More from news
Approximately 11 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • NICE – but not enough NICE – but not enough

    Around the same time (late 2018), Novo Nordisk launched Ozempic, also for type 2 diabetes, though a different class (GLP1). ... market. As. you can see, Ozempic – which launched without a NICE TA – outperformed its rival.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics